Scientific and Medical Equipment House Company (TADAWUL:4014)

TADAWUL:4014 Financials Overview

Financials in millions SAR. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	784.46	876.71	877.23	776.67	713.82	699.45
Revenue Growth	-14.92%	-0.06%	12.95%	8.80%	2.05%	13.28%
Gross Profit Gross Profit Growth	112.84	121.56	133.16	128.75	153.78	152.75
Operating Income Operating Income Growth	37.93	36.39	54.83	74.56	36.17	82.39
Net Income Net Income Growth	28.49	28.44	26.17	40.06	17.57	77.52
Earnings Per Share EPS Growth	0.96	0.95	0.87	1.34	0.59	2.58
EPS Growth	8.38%	8.68%	-34.67%	128.04%	-77.34%	3.70%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Eliminations Eliminations Growth	-19.84	-23.3	-23.1	-16.1	-6.38	-11.7
Medicine and Medical Supplies Medicine and Medical Supplies Growth	23.45	19.24	6.76	5.85	33.76	16.65
Medical Equipment Sales and Post-Sale Maintenance Servies Medical Equipment Sales and Post-Sale Maintenance Servies Growth	74.82	133.52	80.9	71.31	52.89	63.02
Construction Construction Growth	37.92	42.87	55.76	45	65.12	50.08
Maintenance and Operation Maintenance and Operation Growth	643.34	682.25	738.65	662.48	560.83	570.9
Meat and Food Meat and Food Growth	26.76	22.11	18.27	8.12	7.6	10.51
Total Total Growth	786.45	876.71	877.23	776.67	713.82	699.45

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	30.88	20.47	88.06	16.95	54.56	45.32
Total Debt Total Debt Growth	173.6	191.5	208.15	362.83	206.56	266.24
Net Cash (Debt) Net Cash Growth	-142.73	-171.03	-120.09	-345.88	-152	-220.92
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-4.79	-5.70	-4.00	-11.53	-5.07	-7.36

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	78.98	8.75	285.78	-140.64	146.75	-72.04
Capital Expenditures CapEx Growth	-8.11	-7.08	-4.43	-14.88	-13.29	-7.45
Free Cash Flow Free Cash Flow Growth	70.87	1.67	281.35	-155.51	133.46	-79.49
Free Cash Flow Growth	125.97%	-99.41%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	14.38%	13.87%	15.18%	16.58%	21.54%	21.84%
Operating Margin	4.83%	4.15%	6.25%	9.60%	5.07%	11.78%
Pretax Margin	5.01%	4.58%	5.23%	8.00%	3.89%	12.13%
Profit Margin	3.63%	3.24%	2.98%	5.16%	2.46%	11.08%
FCF Margin	9.03%	0.19%	32.07%	-20.02%	18.70%	-11.36%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	1.000	-	1.000	1.000	-	0.667
Dividend Per Share Growth	0%	-	0%	-	-	-33.33%
Dividend Yield	3.64%	-	1.98%	2.09%	-	-

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	28.76	33.46	57.90	35.76	69.56	-
Forward PE	-	31.28	31.28	27.29	-	-
P/FCF Ratio	11.64	570.81	5.39	-	9.16	-
PS Ratio	1.05	1.09	1.73	1.84	1.71	-

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error